5-HTP 50 mg
- Send to friend
- Customers Also Bought
- Customer feedback
5-HTP 50 mg | BioGenesis
5-Hydroxytryptophan (5-HTP) is the immediate precursor in the biosynthesis of the neurotransmitter 5-hydroxytryptamine (5 HT or serotonin). 5-HT is synthesized from the amino acid L-tryptophan.
5-HTP has replaced the use of L-tryptophan in the United States. In 1989 patients taking L-tryptophan developed a negative and debilitating reaction called eosinophilia-myalgia syndrome.
Upon further study it was determined that the culprit was not the L-tryptophan but a bacterial contaminate in the formula. All L-tryptophan products associated with the syndrome were found to come from genetically modified bacterial recombinant production methods.
Even though L- tryptophan was proven to be safe, it never recovered from this incident. 5-HTP was created to fill the gap created by the removal of L-tryptophan from the marketplace.
5-HTP 50 mg | BioGenesis
-HTP 50 mg 120 vcaps
Ingredients per vcapsule:
5-Hydroxy L-Tryptophan 50 mg
As a dietary supplement, take 1-2 capsules twice daily between
meals or as directed by your health care practitioner.
1. Patients on MAOIs (approved 2 weeks after discontinuation)
2. Patients with carcinoid tumors
3. Should not be used concurrently with medications such as: SSRIs, tricyclic antidepressants, MAOIs.
4. Should not be used concurrently with serotonin 5-HT1 receptor agonists including naratriptan, sumatriptan, and zolmitriptan.
5. Patients with ischemic heart disease (Hx of myocardial infarction, angina pectoris, documented silent ischemia)
6. Patients with Hx of coronary artery spasm
7. Uncontrolled hypertension
8. Pregnant women and nursing mothers
Keep out of the reach of children.
Side effects: Due to excessive serotonin production could include:
Nausea, diarrhea, loss of appetite, vomiting, difficult breathing, dilation
of pupils, exaggerated reflexes, loss of muscle coordination, blurring of
vision and cardiac dysrythmias.
Note: Carbidopa may increase 5-HTP transport across the blood brain
barrier due to decreased peripheral 5-HTP metabolism.
Methyldopa inhibits conversion of 5-HTP to serotonin
Disclaimer: The statements enclosed herein have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease
Since we do not know everything about your medical history and medications, please consult with your health care practitioner before implementing any new protocols and supplements. Do not construe any information listed on this site as a substitute for actual medical advice. The info you receive from us is not intended to replace medical advice by your doctor. Forrest Health, Inc. does not dispense medical advice, prescribe, or diagnose illness. We offer nutritional programs and supplements that support your health. The views and nutritional advice expressed by Forrest Health, Inc. are not intended to be a substitute for conventional medical service. If you have a medical condition, see your physician of choice